We analyzed the incidence of neurological complications in 77 patients rece
iving stem cell transplantation (SCT), and 12 patients (15.8%) had the foll
owing symptoms: convulsions, intracranial hemorrhage, and leukoencephalopat
hy, Although statistically not significant, neurological complications were
seen more frequently in patients after allogeneic transplantation, and in
those with acute graft-versus-host disease (GVHD) exceeding grade II. The m
ost significant risk factor for neurological complications was identified a
s unrelated donor allogenic transplantation (P = 0.016). Complications were
categorized into three groups, based on time of onset and symptoms: (1) co
nvulsions during the conditioning period, (2) intracranial hemorrhage durin
g the period of granulocyte recovery, and (3) leukoencephalopathy at around
2 months after SCT, We propose awareness of the risks of neurological comp
lications in each period after SCT so that immediate and effective treatmen
t of patients can be instigated.